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Abstract
Background: Hippocampal slices swell and release taurine during oxidative stress. The influence of cellular
signalling pathways on this process is unclear. Glutamate signalling can facilitate volume regulation in other CNS
preparations. Therefore, we hypothesize activation of taurine release by oxidative stress results from tissue swelling
and is coupled to activation of glutamate receptors.
Methods: Rat hippocampi were incubated at room temperature for 2 hr in artificial cerebrospinal fluid (aCSF)
equilibrated with 95% O2 plus 5% CO2. For some slices, 1 mM taurine was added to the aCSF to maintain normal
tissue taurine content. Slices then were perfused with aCSF at 35° C and baseline data recorded before 2 mM H2O2
was added. For some studies, mannitol or inhibitors of glutamate receptors or the volume-regulated anion channel
(VRAC) were added before and during H2O2 treatment. The intensity of light transmitted through the slice (the
intrinsic optical signal, IOS) was determined at 1-min intervals. Samples of perfusate were collected at 2-min
intervals and amino acid contents determined by HPLC. Data were analyzed by repeated measures ANOVA and
post hoc Dunnett’s test with significance indicated for p<0.05.
Results: IOS of slices prepared without taurine treatment increased significantly by 3.3±1.3% (mean±SEM) during
oxidative stress. Little taurine was detected in the perfusate of these slices and the rate of taurine efflux did not
change during H2O2 exposure. The a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate antagonist, 25 µM CNQX,
but not the N-methyl-D-aspartate (NMDA) receptor antagonist, 10 µM MK-801, inhibited the increase in IOS during
H2O2 treatment. Taurine-treated slices exposed to H2O2 showed no change in IOS; however, taurine efflux
increased by 335±178%. When these slices were perfused with hypertonic aCSF (350 mOsm) or exposed to the
VRAC inhibitor, 20 µM DCPIB, no increase in the taurine efflux rate was observed during H2O2 exposure. Taurine-
treated slices perfused with 10 µM MK-801 during H2O2 exposure showed a 4.6±1.9% increase in IOS but no
increase in the taurine efflux rate.
Conclusions: Taurine efflux via VRAC is critical for volume regulation of hippocampal slices exposed to oxidative
stress. This increased taurine efflux does not result from direct activation of the taurine release pathway by H2O2.
NMDA receptor activation plays an important role in taurine release during oxidative stress.
Background
Oxidative stress is observed following brain injury
caused by a variety of mechanisms and contributes to
secondary brain injury. Brain edema in ischemic and
hemorrhagic stroke is associated with production of
reactive oxygen species (ROS) and resultant oxidative
stress [1,2]. Endogenous and exogenous anti-oxidants
reduce edema formation and brain damage following
ischemia and reperfusion [1,3-5] and intracerebral
hemorrhage [2,6]. Reactive oxygen species (ROS) may
directly precipitate brain swelling without inducing
ischemia or blood-brain barrier injury during intracra-
nial hemorrhage and excitotoxic injury [7,8].
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brain tissue swelling through activation of glutamate
receptors [9]. Because of their direct activation of ion
channels and resultant osmotic sequelae, ionotropic glu-
tamate receptors may play a significant role in initiating
this brain tissue swelling. Indeed, brain swelling during
exposure to H2O2 is inhibited by ionotropic glutamate
receptor antagonists [9]. Brain edema also is modified
by metabotropic glutamate receptor activation in certain
models of traumatic brain injury and excitotoxicity
[10-12]; however, other investigators have seen no effect
of the metabotropic group II receptor [12] on injury-
induced brain edema.
In addition to causing brain edema, activation of glu-
tamate receptors may modify the response of CNS
cells to swelling through actions on cell volume regula-
tory mechanisms [13,14]. Neurons and glial cells, like
many other cell types, facilitate swelling-induced
volume regulation by activating volume-regulated
anion channels (VRAC) which cause efflux of taurine
and other organic osmolytes [15-17]. Thus, glutamater-
gic signaling during oxidative stress may indirectly lead
to brain swelling by modifying this normal cell volume
regulation mechanism. This study focuses on ionotro-
pic glutamate signaling during hippocampal oxidative
stress. We examine whether this pathway directly
induces brain swelling or modifies brain cell volume
regulation via the VRAC.
Methods
All experiments involving animals were approved by the
Laboratory Animal Care and Use Committee of Wright
State University and conform to the Guide for the Care
and Use of Laboratory Animals. Slices of hippocampus
were prepared using methods similar to those previously
described [18]. Adult Sprague Dawley male rats (275-
350 g) were anesthetized to apnea with Isoflurane and
then perfused over 1 min via the left cardiac ventricle
with 100 ml of ice-cold artificial cerebrospinal fluid
(aCSF) consisting of 124 mM NaCl, 3.5 mM KCl, 2 mM
CaCl2,1m MM g S O 4,1m MN a H 2PO4,2 6m M
NaHCO3, and 10 mM glucose. The aCSF osmolality was
adjusted to 290 mOsm with additions of small volumes
of 3 M NaCl and was equilibrated with 95% O2 plus 5%
CO2 prior to use. This perfusion treatment flushed away
blood and rapidly chilled the brain tissue. The brain was
removed from the head and placed in a slurry of ice-
cold aCSF. After 5-6 min, the hippocampus was dis-
sected from the brain and cut into 400 µM slices with a
McIlwain chopper. These slices were incubated for 2-4
hr in room temperature aCSF that was constantly
bubbled with 95% O2 plus 5% CO2. Hippocampal slices
prepared in this manner lose 70% to 80% of endogenous
taurine contents [18]. Therefore, for some slices, the
aCSF solutions used during incubation also contained
1 mM taurine to maintain normal taurine contents.
After the room temperature incubation period, slices
were transferred to the recording stage of a Haas-type
interface chamber and perfused with aCSF equilibrated
with 95% O2 plus 5% CO2 at 35° C under an atmosphere
of humidified 95% O2 plus 5% CO2. For slices exposed to
1 mM taurine during room temperature incubation, the
same taurine concentration was present during the first
30 min of perfusion on the recording stage. After a total
of 90 min on the recording stage, 2 mM H2O2 was added
to the perfusing aCSF to produce oxidative stress. For
slices treated with pharmacological agents, the drugs
were added to the aCSF beginning 15 min prior to the
start and then throughout the period of H2O2 exposure.
The intrinsic optical signal (IOS) was recorded as an
indirect measure of changes in tissue volume [18,19].
Slices were illuminated with a DC regulated light source
while the light transmitted through the slice was recorded
with a video camera and captured as uncompressed digital
images every 60 sec. The average pixel intensity was calcu-
lated for identified regions of the stratum radiatum of the
CA1 region interest using ImageJ software.
Effluent perfusate from the recording stage was col-
lected continually during the experiments and pooled in
2 min aliquots. A 1 ml sample was removed from each
aliquot, frozen at -70° C, lyophilized, and then stored at
-70° C for later analysis. The residue was dissolved in 100
µl of distilled water and 65 µl was used for HPLC analysis
of amino acid concentration following derivatization with
o-pthalaldehyde as previously described [18,20].
AMPA (a-amino-3-hydroxyl-5-methyl-4-isoxazole-pro-
pionate), CNQX (6-cyano-7-nitroquinoxaline-2,3-dione),
and MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]
cyclohepten-5,10-imine maleate) were obtained from
Sigma-Aldrich (St. Louis, Missouri). DCPIB (4-[(2-Butyl-
6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-ox o-1H-inden-
5-yl)oxy]butanoic acid) was purchased from Tocris
Biosciences (Ellisville, Missouri). All other chemicals were
from Fischer Scientific (Hanover Park, Illinois) and were
the highest grade available.
IOS and amino acid contents were analyzed by
repeated measures ANOVA followed by post hoc Dun-
nett’s test to compare data obtained during oxidative
stress with values measured during the baseline period
prior to H2O2 exposure. Significance was indicated for
p<0.05.
Results
Taurine is necessary for volume regulation during
oxidative stress
Hippocampal slices prepared with incubation in normal
aCSF without added taurine demonstrated a significant
increase in IOS during exposure to H2O2 (Figure 1.A.).
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slices and the taurine concentration did not increase
during peroxide exposure (data not shown). In contrast,
slices incubated with 1 mM taurine showed little swel-
ling throughout the period of oxidative stress while the
concentration of taurine in the perfusate increased over
3-fold during this period (Figure 1.B.).
Taurine efflux occurs via VRAC to control swelling during
oxidative stress
We tested whether the increase in taurine release during
oxidative stress was due to cell swelling or direct activa-
tion of VRAC by H2O2[21,22]. For these studies, the
osmolality of the aCSF perfusing taurine-treated slices
was increased to 350 mOsm with the addition of
Figure 1 Tissue swelling and taurine efflux from the hippocampus during oxidative stress. Hippocampal slices were perfused with aCSF
containing 2 mM H2O2 from t = 0 min to the end of the data sampling period shown. Values are the mean ± SEM for 3-12 independent
measurements. (A) The intrinsic optical signal (IOS) was calculated for areas of the stratum radiatum in the CA1 region of the hippocampus.
Slices incubated with normal aCSF during preparation (solid symbols) showed a significant increase in IOS during exposure to H2O2 while slices
incubated with 1 mM taurine (hollow symbols) showed little change in IOS. (B) Taurine concentrations were measured in the effluent of the
aCSF that perfused hippocampal slices prepared with 1 mM taurine to maintain normal taurine contents. The taurine concentration in the aCSF
perfusate increased significantly at the start of H2O2 exposure and remained elevated for 10 min. * indicates values which are significantly
different from the baseline measurements determined prior to H2O2 treatment.
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the perfusate. Mannitol treatment markedly and
rapidly decreased the IOS by 17.0±2.2% within 10 min
(mean±SEM). No increase in taurine efflux was observed
in these slices during the subsequent exposure to oxida-
tive stress.
In the presence of the VRAC inhibitor, 20 µM DCPIB
[23], slices incubated with taurine and then perfused
with normal aCSF (290 mOsm) demonstrated an
increase in IOS but no increase in taurine efflux during
exposure to 2 mM H2O2 (Table 1).
Glutamate signalling is coupled to volume regulation
during oxidative stress
To examine the role of glutamate signalling for oxidative
stress-induced swelling and volume regulation, hippo-
campal slices were exposed to an inhibitor of either N-
methyl-D-aspartate (NMDA) receptors (10 µM MK-801)
or AMPA receptors (25 µM CNQX). In slices without
taurine treatment, no change in IOS was observed when
2m MH 2O2 was added to the perfusate in the presence
of CNQX. This suggests AMPA receptors contribute to
the mechanisms of swelling induced by oxidative stress.
In contrast, in the presence of MK-801, the mean±SEM
IOS increased by 1.8±0.2% during 25 min of peroxide
exposure; a value that is similar to that observed in the
absence of drug (Figure 1). However, when taurine-trea-
ted slices were exposed to H2O2 in the presence of MK-
801, a significant increase in IOS was seen, and the rate
of taurine efflux was not altered (Table 1).
Discussion
The results of these experiments illuminate several
mechanisms for swelling and volume regulation of the
hippocampus exposed to oxidative stress. First, the data
demonstrate the importance of intracellular taurine for
volume regulation in this condition. We previously
demonstrated that hippocampal slices lose the majority
of their taurine content during preparation and incuba-
tion unless exogenous taurine is added to the incubation
solutions [18]. Our previous data also demonstrated that
a normal tissue taurine content was critical for volume
regulation of the hippocampus swollen by exposure to
hypoosmotic conditions. The present results reveal a
similar requirement of normal taurine content for
volume regulation during exposure to oxidative stress in
isoosmotic conditions. Furthermore, inhibition of oxida-
tive stress-induced taurine efflux by the VRAC anta-
gonist, DCPIB, and the tissue swelling which results in
the presence of this drug, indicates that taurine efflux is
n e c e s s a r yf o rt h ev o l u m er e g u l a t o r yr e s p o n s e .O t h e r s
have demonstrated the release of amino acids through
VRAC channels during exposure to hypoosmotic condi-
tions and oxidative stress [24-26]. We characterized
VRAC in rat astrocytes and neurons in primary culture
during exposure to hypoosmotic conditions [16,27] and
showed that taurine efflux via VRAC is necessary for
hypoosmotic volume regulation in the hippocampus
[18]. Inhibition of oxidative stress-induced taurine efflux
by pre-treatment with hyperosmolar aCSF demonstrates
that H2O2 is not acting directly on VRAC to induce
taurine efflux as has been observed in cell culture
preparations [21,28].
Our data also suggest that the AMPA subtype of iono-
tropic glutamate receptors contributes to hippocampal
swelling induced by oxidative stress while NMDA recep-
tors have little effect. Previous reports have shown that
swelling of hippocampal slices exposed to H2O2 for 1-3
hours can be blocked using a cocktail of glutamate
receptor inhibitors; however, individual contributions of
NMDA and AMPA receptors for the swelling response
w e r en o te l u c i d a t e d[ 2 9 ] .W ed i dn o te x a m i n et h e
effects of metabotropic glutamate receptors in the brain
tissue swelling response. Potentially, activation of group
I or group II receptors may indirectly exacerbate or
reduce swelling, respectively, by modifying endogenous
glutamate release and resulting stimulation of ionotropic
receptors [10,11,30].
Finally, our results demonstrate that glutamate signal-
ing via NMDA receptors plays an important role in
volume regulation of the hippocampus during oxidative
stress. Since oxidative stress-induced swelling itself is
b l o c k e db yC N Q X ,w ec o u l dn o td e t e r m i n ew h e t h e r
AMPA receptors also may be involved in the volume
regulatory response. We and others have described sev-
eral signaling pathways involved in cell volume
Table 1 Drug effects on tissue swelling and taurine efflux from the hippocampus during oxidative stress
Drug Treatment H2O2-induced Change in IOS
(Percent of Baseline)
H2O2-induced Change in Taurine Efflux Rate
(Percent of Baseline)
None 0.7 ± 0.6 % 335 ± 178 % *
20 µM DCPIB 3.2 ± 1.0 % * -11 ± 29 %
10 µM MK-801 4.6 ± 1.9 % * -55 ± 13 %
All experiments were performed using hippocampal slices prepared with 1 mM taurine to maintain normal taurine contents. Changes in the intrinsic optical
signal (IOS) measured in the stratum radiatum of the CA1 region and the taurine efflux rate were determined after 25 min and 8 min of H2O2 exposure,
respectively. These represent time points which resulted in peak responses observed in control slices with no drug treatment as shown in Figure 1. Values are
the mean ± SEM for 3-5 independent measurements. * Indicates values which are significantly different from baseline measurements determined prior toH 2O2
treatment.
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cells. These include the calcium/calmodulin pathway
[24,31,32], nucleotide receptors [16,26], arachidonate
metabolism [22,33] and glutamate receptor activation
[13,14]. The relationships between these pathways as
well as the interactions between glia and neurons which
facilitate brain volume regulation have not yet been fully
described. Greater understanding of these mechanisms
will lead to improved treatments for brain edema and
will reduce the degree of permanent brain damage in
patients who suffer brain injury.
Conclusions
1. Release of taurine from intracellular stores is critical
for isoosmotic volume regulation of the hippocampus
exposed to oxidative stress.
2. Taurine is lost from hippocampal cells during oxida-
tive stress via the volume activated anion channel (VRAC).
3. AMPA receptors, but not NMDA receptors are
coupled to hippocampal swelling during oxidative stress.
4. Volume regulation of the hippocampus is regulated,
in part, by glutamate signaling via NMDA receptors.
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